CBIO
Crescent Biopharma
CBIO
CBIO
28 hedge funds and large institutions have $114M invested in Crescent Biopharma in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$352K | |
| 2 | +$170K | |
| 3 | +$112K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$112K |
| 5 |
Morgan Stanley
New York
|
+$100K |
Top Sellers
| 1 | -$734K | |
| 2 | -$658K | |
| 3 | -$209K | |
| 4 |
Goldman Sachs
New York
|
-$134K |
| 5 |
Blackstone Inc
New York
|
-$119K |